艾德生物(300685.SZ)发布前三季度业绩，归母净利润2.63亿元，增长15.50%

Core Insights - The company reported a revenue of 866 million yuan for the first three quarters of 2025, representing a year-on-year growth of 2.08% [1] - The net profit attributable to shareholders was 263 million yuan, showing a year-on-year increase of 15.50% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 250 million yuan, reflecting a year-on-year growth of 18.05% [1] - The basic earnings per share stood at 0.67 yuan [1]